Publicidad
Caso clínico 10 de setiembre de 2012

Utilidad del PET-CT en el estadiaje y valoración de respuesta al tratamiento en un segundo tumor primario pulmonar

Referenciar Imprimir Descargar PDF

Referencias

  1. Guzman P, Villaseca M, Antonio L, et al. Carcinoma epidermoide oral y orofaríngeo. Estudio Clínico patológico. Rev Chil Cir 2011;63:250-6.
  2. López C, Estelles E, Carrasco M, et al. Neoplasias malignas múltiples en el cáncer escamoso de cabeza y cuello. Acta Otorrinolaringol Esp 2008;59:427-32.
  3. Choi M, Craft B, Geraci SA. Surveillance and monitoring of adult cancer survivors. Am J Med 2011;124:598-601.
  4. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified sqamous cell epithelium; clinical implications of multicentric origin. Cancer 1953;6:963-8.
  5. Cabanillas R, LLorente JL. The stem cell network model: clinical implications in cancer. Eur Arch Otorhinolaryngol 2009;266:161-70.
  6. Morris LG, Sikora AG, Hayes RB, et al. Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer. Canc Causes Contr 2011; 22: 671-679.
  7. Morris LG, Sikora AG, Patel SG, et al. Second primary cancers after an index head and neck cancer: subsites-speficic trends in the era of human papillomavirus associated oropharyngeal cancer. J Clin Oncol 2011;29:739-46.
  8. Peck BW, Dahlstrom KR, Gan SJ. Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck 2012; Jun 19 (Epub ahead of print).
  9. Brouwer J, de Bree R, Hoekstra OS, et al. Screening for distant metastases in patients with head and neck cancer: is chest computed tomography sufficient? Laryngoscope 2005;115:1813-7.
  10. Xu GZ, Guan DJ, He ZY.18FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis. Oral Oncol 2011;47:560-5.
  11. Ng SH, Chan SC, Yen TC, et al. Pretreatment evaluation of distant-site status with nasopharyngeal carcinoma: accuracy of whole body MRI at 3-tesla and FDG-PET-CT. Eur Radiol 2009;19:1366-78.
  12. Ng SH, Chan SC, Yen TC, et al. Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 8 T compared with FDG-PET-CT. Eur Radiol 2010;20: 2229-40.
  13. Li F, Sturgis EM, Chen X, et al. Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck. Cancer 2010;16:2350-9.
  14. Lei D, Sturgis EM, Liu Z, et al. Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Carcinogenesis 2010;31:222-7.